IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • Presentations
    • Scientific Publications & Posters
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Info
    • Proxy Info
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us
  • FAQ
May 29, 2013 8:05am EDT

Immunovaccine to Present Clinical Data on its DPX-Survivac Cancer Vaccine at the 2013 ASCO Annual Meeting

May 16, 2013 5:05pm EDT

Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013

Jan 30, 2013 8:05am EST

Immunovaccine Signs Agreement for Phase I/II Clinical Trial of DPX-0907 in Breast and Ovarian Cancer Patients

Jan 07, 2013 8:05am EST

Immunovaccine's DPX-Survivac Produces Sustained, Dose Related Immune Responses in Phase I Ovarian Cancer Study

Jan 03, 2013 8:05am EST

Immunovaccine Reports Positive Results from Ongoing Study of DepoVax(TM)-Based Anthrax Vaccines

Nov 16, 2012 8:05am EST

Immunovaccine Announces Financial Results for the Quarter Ended September 30, 2012

Oct 02, 2012 12:39pm EDT

Immunovaccine Inc. to Webcast, Live, at RetailInvestorConferences.com on October 4th

Sep 20, 2012 1:04pm EDT

Immunovaccine Adds Scott Halperin, M.D., to Scientific Advisory Board

Sep 04, 2012 8:05am EDT

Immunovaccine to Present at Rodman & Renshaw 14th Annual Global Healthcare Conference

Aug 17, 2012 8:05am EDT

Immunovaccine Announces Financial Results for the Quarter Ended June 30, 2012

RSS
  • Prev
  • 1...
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • ...40
  • Next
  • Email Alerts
  • Contacts
  • RSS News Feed
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2022 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap